Form 4 for WST West Pharmaceutical Services
Accepted 2024-10-31 00:00:00 ET · period of report 2024-10-29 · accession 0001127602-24-026141 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-31 | 2024-10-29 | WST | Witherspoon Charles | VP, Treas | S - Sale+OE | $310.40 | -703 | 1,478 | -32% | -$218.2K |
| D | 2024-10-31 | 2024-10-29 | WST | Witherspoon Charles | VP, Treas | M - OptEx | $173.22 | +478 | 1,956 | +32% | +$82.8K |
| D | 2024-10-31 | 2024-10-29 | WST | Witherspoon Charles | VP, Treas | M - OptEx | $0.00 | -478 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-29 | S | D | 225 | $310.40 | 1,253.14 | D | — | — | |
| 2 | Common | Common Stock | 2024-10-29 | M | A | 478 | $173.22 | 1,956.14 | D | — | — | |
| 3 | Common | Common Stock | 2024-10-29 | S | D | 478 | $310.40 | 1,478.14 | D | — | — | |
| 4 | Derivative | Stock Options (Right to Buy) | 2024-10-29 | M | D | 478 | $0.00 | 0 | D | $173.22 · 2021-02-18 to 2030-02-18 | 478 Stock Options (Right to Buy) | (F1) This award vested in four equal annual installments beginning on February 18, 2021. |